Vizimpro

Medicinal product

(Invented) name

Vizimpro

Active substance (s)

Dakomitinibas

Strength

30 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EB07, dacomitinib

Marketing authorisation holder

Pfizer Europe MA EEIG, Belgija

Date of authorisation

2019-04-02

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Dakomitinibas	30 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
101382	87485	1087485	lizdinė plokštelė	N30		Receptinis	EU/1/19/1354/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-04-02	Registruotas